!!! Important information for NIH authors !!!
Cellular Signalling publishes full-length, original papers, written in a concise style, that describe key, novel findings on all aspects
of mechanisms, actions and structural components of cellular signalling systems. The emphasis is on:• effector systems, such
as protein kinases, lipid signalling pathways, cyclic nucleotide signalling ... click here for full Aims & Scope
Cellular Signalling publishes full-length, original papers, written in a concise style, that describe key, novel findings on all aspects
of mechanisms, actions and structural components of cellular signalling systems. The emphasis is on:
• effector systems, such
as protein kinases, lipid signalling pathways, cyclic nucleotide signalling processes, NO signalling and ion channels;
• the
production, regulation, degradation and action of second messengers; the structure, regulation, degradation and action of receptors;
• guanine nucleotide regulatory proteins;
• bio-informatic studies related to cell signalling mechanisms;
•
compartmentalisation/compartmentation of signalling systems;
• anchor/scaffold signalling proteins;
• the effect of
cellular signalling events on the functioning, growth and differentiation of cells in normal and pathological states and also cellular
oncogenes.
Within the scope of the journal, manuscripts dealing with biochemistry, protein structure, cell biology, molecular biology,
pharmacology, neurobiology, molecular endocrinology and molecular oncology are welcomed.
The journal does not publish short reports.
Cellular Signalling will also publish Topical Reviews of some five thousand to eight thousand words. In general, reviews will be
solicited by the Editorial Board. However, intending contributors of unsolicited review articles can send a brief summary of their proposed
Topical Review to the Editorial Office for comment on its possible acceptability prior to submission.
Publishing Contact
Publishing Editor: Simone Groothuis, E-mail: s.groothuis@elsevier.com
Hide Aims & Scope
Editor-in-Chief: Contact the Editor
Miles Houslay